Patents by Inventor Natallia Kulyba

Natallia Kulyba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF ASSESSING ANTIBODY-DRUG CONJUGATES
    Publication number: 20210172866
    Abstract: The present disclosure provides methods of assessing DAR of ADC products that provide advantages over known methods. Specifically, methods of the disclosure can be used in high-throughput applications and/or without having to dilute ADC samples during the assessment.
    Type: Application
    Filed: February 19, 2021
    Publication date: June 10, 2021
    Inventors: Andria SKINNER, Natallia KULYBA
  • Methods of assessing antibody-drug conjugates
    Patent number: 10976241
    Abstract: The present disclosure provides methods of assessing DAR of ADC products that provide advantages over known methods. Specifically, methods of the disclosure can be used in high-throughput applications and/or without having to dilute ADC samples during the assessment.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: April 13, 2021
    Assignee: Regeneran Pharmaceuticals, Inc.
    Inventors: Andria Skinner, Natallia Kulyba
  • METHODS OF ASSESSING ANTIBODY-DRUG CONJUGATES
    Publication number: 20190079005
    Abstract: The present disclosure provides methods of assessing DAR of ADC products that provide advantages over known methods. Specifically, methods of the disclosure can be used in high-throughput applications and/or without having to dilute ADC samples during the assessment.
    Type: Application
    Filed: September 5, 2018
    Publication date: March 14, 2019
    Inventors: Andria Skinner, Natallia Kulyba